Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $492,803 - $1.08 Million
5,419 Added 1293.32%
5,838 $531,000
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $1.12 Million - $1.24 Million
-7,194 Reduced 94.5%
419 $68,000
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $764,660 - $919,510
5,778 Added 314.88%
7,613 $1.21 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $188,179 - $248,330
1,835 New
1,835 $248,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.